• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用 Amplazter 导管封堵器 I 闭合膜周部室间隔缺损合并瘤样组织:经验教训和中期随访。

Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.

机构信息

Division of Pediatric Cardiology, Rady Children's Hospital-San Diego, San Diego, California, USA.

出版信息

Catheter Cardiovasc Interv. 2012 Nov 15;80(6):895-903. doi: 10.1002/ccd.23074. Epub 2012 Aug 20.

DOI:10.1002/ccd.23074
PMID:22907908
Abstract

OBJECTIVES

The aim of this report is to describe our experience with closure of perimembranous ventricular septal defects (PMVSD) with aneurysm using the Amplatzer Duct Occluder I (ADO I).

BACKGROUND

Atrio-ventricular block (AVB) remains the most troublesome complication of device closure of PMVSDs. Many PMVSDs are associated with an aneurysm that protrudes into the right ventricle. We believe that devices implanted entirely within the VSD aneurysm avoid the risk of AVB.

METHODS

A retrospective analysis of patients with PMVSD and aneurysm who underwent attempted ADO I device closure between 3/2004 and 8/2010 [Rady Children's Hospital-San Diego (n = 16), Mattel Children's Hospital at UCLA (n = 4), and Straub Hospital in Honolulu (n = 1)].

RESULTS

Twenty-one patients (16 male) with PMVSD and aneurysm underwent cardiac catheterization for the purpose of VSD closure using an ADO I. Nineteen patients had successful ADO I implantation with the following devices: 10/8 (n = 8), 8/6 (n = 7), 6/4 (n = 3) and 12/10 (n = 2). The procedure was aborted in 2 cases due to temporary AVB and ventricular ectopy during catheterization. One patient developed hemolysis due device malposition and had surgical device retrieval and VSD closure. One patient had new trivial tricuspid regurgitation and in 5/19 the tricuspid regurgitation improved post device closure. Transient accelerated junctional rhythm occurred within 24 hr in 4 patients and nonsustained slow ventricular tachycardia occurred in one patient. At latest follow-up (up to 6 years, median 1.9 years) 11/18 had no residual shunt, 4/18 had trivial and 3/18 small residual shunt. No AVB has been observed.

CONCLUSIONS

Percutaneous closure of PMVSD with aneurysm using the ADO I appears to have acceptable efficacy and risk. Atrio-ventricular block in up to mid-term follow up was not encountered.

摘要

目的

本报告旨在描述我们使用 Amplatzer 导管封堵器 I(ADO I)治疗膜周部室间隔缺损(PMVSD)合并瘤的经验。

背景

房室传导阻滞(AVB)仍然是 PMVSD 器械封堵最麻烦的并发症。许多 PMVSD 合并有向右侧心室突出的瘤。我们认为,完全植入 VSD 瘤内的器械可以避免 AVB 的风险。

方法

回顾性分析 2004 年 3 月至 2010 年 8 月期间在 Rady 儿童医院-圣地亚哥(n = 16)、UCLA Mattel 儿童医院(n = 4)和檀香山 Straub 医院(n = 1)接受 ADO I 尝试封堵 PMVSD 和瘤的患者。

结果

21 例 PMVSD 合并瘤患者接受了心脏导管术,目的是使用 ADO I 封堵 VSD。19 例患者成功植入 ADO I,使用的器械如下:10/8(n = 8)、8/6(n = 7)、6/4(n = 3)和 12/10(n = 2)。2 例因导管插入术中出现暂时性 AVB 和室性异位而中止手术。1 例因器械位置不当发生溶血,行手术取出器械并关闭 VSD。1 例患者出现新的轻微三尖瓣反流,在 19 例患者中,5 例患者的三尖瓣反流在器械封堵后改善。4 例患者在 24 小时内出现短暂加速交界性节律,1 例患者出现非持续缓慢室性心动过速。在最新随访时(最长 6 年,中位随访时间 1.9 年),18 例患者中 11 例无残余分流,4 例有轻微残余分流,3 例有小残余分流。未观察到 AVB。

结论

使用 ADO I 经皮封堵 PMVSD 合并瘤的疗效和风险似乎可以接受。在中期随访中未发现房室传导阻滞。

相似文献

1
Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up.应用 Amplazter 导管封堵器 I 闭合膜周部室间隔缺损合并瘤样组织:经验教训和中期随访。
Catheter Cardiovasc Interv. 2012 Nov 15;80(6):895-903. doi: 10.1002/ccd.23074. Epub 2012 Aug 20.
2
Transcatheter closure of perimembranous ventricular septal defect using Amplatzer ductal occluder.应用 Amplatzer 导管封堵器经导管闭合膜周部室间隔缺损。
Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1141-6. doi: 10.1002/ccd.24810. Epub 2013 Aug 20.
3
[Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].[应用Amplatzer II型动脉导管封堵器经导管闭合膜周部和肌部室间隔缺损的疗效]
Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Oct;40(10):817-20.
4
Outcomes of a modified approach to transcatheter closure of perimembranous ventricular septal defects.改良经导管膜周部室间隔缺损封堵术的疗效。
Catheter Cardiovasc Interv. 2013 Jul 1;82(1):143-9. doi: 10.1002/ccd.24774. Epub 2013 Feb 21.
5
The results of transcatheter closure of VSD using Amplatzer® device and Nit Occlud® Lê coil.应用 Amplatzer 装置和 Nit Occlud®Lê 线圈经导管闭合室间隔缺损的结果。
Catheter Cardiovasc Interv. 2011 Dec 1;78(7):1032-40. doi: 10.1002/ccd.23084. Epub 2011 Jun 6.
6
Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre.单中心经导管封堵膜周部室间隔缺损的发展历程
Catheter Cardiovasc Interv. 2009 Mar 1;73(4):568-75. doi: 10.1002/ccd.21885.
7
[Outcome of transcatheter closure of perimembranous ventricular septal defect with modified double-disk occluder device].[应用改良双盘封堵器经导管闭合膜周部室间隔缺损的疗效]
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Apr;38(4):321-5.
8
Transcatheter closure of perimembranous ventricular septal defects: initial human experience with the Amplatzer® membranous VSD occluder 2.经导管膜周部室间隔缺损封堵术:Amplatzer®膜部 VSD 封堵器 2 的初步人体经验。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):474-9. doi: 10.1002/ccd.24361. Epub 2013 May 15.
9
Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: Why limitation in sizes?使用近乎理想的Amplatzer II型动脉导管封堵器经皮闭合膜周部室间隔缺损:为何存在尺寸限制?
Congenit Heart Dis. 2019 May;14(3):389-395. doi: 10.1111/chd.12731. Epub 2018 Dec 18.
10
Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results.杂交经胸微创室缺封堵术治疗双出口型室间隔缺损:中期结果。
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E225-32. doi: 10.1002/ccd.24869. Epub 2013 Apr 8.

引用本文的文献

1
Optimized retrograde approach and device selection with Konar-MF™ for pediatric transcatheter ventricular septal defect closure.采用Konar-MF™进行小儿经导管室间隔缺损封堵时的优化逆行入路及器械选择
Turk Gogus Kalp Damar Cerrahisi Derg. 2025 Jul 21;33(3):301-311. doi: 10.5606/tgkdc.dergisi.2025.27178. eCollection 2025 Jul.
2
Pulmonary hypertension in adults with congenital heart defects (ACHDs) in light of the 2022 ESC PAH guidelines-part II: supportive therapy, special situations (pregnancy, contraception, non-cardiac surgery), targeted pharmacotherapy, organ transplantation, special management (shunt lesion, left ventricular disease, univentricular hearts), interventions, intensive care, ACHD follow-up, future perspective.根据2022年欧洲心脏病学会肺动脉高压指南看成人先天性心脏病(ACHD)中的肺动脉高压——第二部分:支持治疗、特殊情况(妊娠、避孕、非心脏手术)、靶向药物治疗、器官移植、特殊管理(分流病变、左心室疾病、单心室心脏)、干预措施、重症监护、ACHD随访、未来展望
Cardiovasc Diagn Ther. 2024 Oct 31;14(5):921-934. doi: 10.21037/cdt-24-167. Epub 2024 Oct 22.
3
[Interventionism in congenital heart disease in Chiapas. The history after thousand cases performed].[恰帕斯州先天性心脏病的干预治疗。千例手术之后的历程]
Arch Cardiol Mex. 2024 Feb 1;94(3):300-308. doi: 10.24875/ACM.23000170.
4
Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects.经皮导管封堵先天性室间隔缺损
Korean Circ J. 2023 Mar;53(3):134-150. doi: 10.4070/kcj.2022.0336.
5
Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighing ≤ 10 kg.经股动脉膜周部室间隔缺损封堵术在体重 ≤ 10 kg 婴儿中的应用。
Pediatr Cardiol. 2023 Jun;44(5):1176-1182. doi: 10.1007/s00246-023-03100-5. Epub 2023 Jan 25.
6
Experiences of Two Centers in Percutaneous Ventricular Septal Defect Closure Using Konar Multifunctional Occluder.经 Konar 多功能封堵器行经皮室间隔缺损封堵的两中心经验。
Anatol J Cardiol. 2022 Apr;26(4):276-285. doi: 10.5152/AnatolJCardiol.2021.464.
7
Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Lifetech Konar-Multi Functional Occluder: Early to Midterm Results of the Indonesian Multicenter Study.使用先健科纳多功能封堵器经导管闭合膜周部室间隔缺损:印度尼西亚多中心研究的早期至中期结果
Glob Heart. 2022 Feb 24;17(1):15. doi: 10.5334/gh.1106. eCollection 2022.
8
Transcatheter Closure of Perimembranous Ventricular Septal Defect with Aneurysm: Radiologic Characteristic and Interventional Strategy.经导管膜周部室间隔缺损合并瘤样突起的封堵:影像学特征与介入策略。
J Interv Cardiol. 2020 Dec 24;2020:6646482. doi: 10.1155/2020/6646482. eCollection 2020.
9
Short- and Long-term Outcome After Interventional VSD Closure: A Single-Center Experience in Pediatric and Adult Patients.介入性 VSD 闭合术的短期和长期结果:儿科和成年患者的单中心经验。
Pediatr Cardiol. 2021 Jan;42(1):78-88. doi: 10.1007/s00246-020-02456-2. Epub 2020 Oct 3.
10
Transcatheter Closure of Perimembranous Ventricular Septal Defects Using Different Generations of Amplatzer Devices: Multicenter Experience.应用不同代次的 Amplatzer 封堵器经导管闭合膜周部室间隔缺损:多中心经验。
J Interv Cardiol. 2020 Feb 21;2020:8948249. doi: 10.1155/2020/8948249. eCollection 2020.